Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antibiotic Discovery
Mpex signs agreement with discovery chemistry company
October 27th, 2003
Mpex Pharmaceuticals, Inc., and Chemical Diversity Labs, Inc., (CDL) announced that they have entered into an agreement where CDL will provide Mpex with a diverse library of 100,000 small-molecule compounds to support the discovery of new antibacterial agents. In addition to compound libraries, CDL will also provide various chemistry services to support the optimization of leads identified from the collaboration. Financial terms were not disclosed. Mpex is pursuing the discovery of next-generation antibiotics that meet the growing clinical need created by multidrug-resistant bacterial pathogens. To identify these new agents, Mpex is utilizing its...
Source: Health & Medicine Week (2003-10-27)
|
